Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q3 2024 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2024-10-15

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Oct 15, 2024

Total Value: $529M (100.0% shares, 0.0% debt)

Holdings (4)

CNTA CENTESSA PHARMACEUTICALS PLC 60.4%

Value $319M Shares 19,963,157 Share Price $15.99 Est. Cost/Share $20.88 Unrealized @ Report Date —

PHAT PHATHOM PHARMACEUTICALS INC 25.5%

Value $135M Shares 7,464,572 Share Price $18.08 Est. Cost/Share $13.72 Unrealized @ Report Date +31.8%

NAMS NEWAMSTERDAM PHARMA COMPANY 9.0%

Value $47.63M Shares 2,869,565 Share Price $16.60 Est. Cost/Share $10.96 Unrealized @ Report Date +51.5%

AURA AURA BIOSCIENCES INC 5.1%

Value $27.09M Shares 3,039,892 Share Price $8.91 Est. Cost/Share $17.87 Unrealized @ Report Date -50.1%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$319M	60.4%	$15.99	$20.88	—	SPONSORED ADS	152309100
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$135M	25.5%	$18.08	$13.72	+31.8%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$47.63M	9.0%	$16.60	$10.96	+51.5%	ORDINARY SHARES	N62509109
AURA	AURA BIOSCIENCES INC	3,039,892	$27.09M	5.1%	$8.91	$17.87	-50.1%	COM	05153U107